Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.235 USD | +2.81% | +1.50% | +59.84% |
Business Summary
Number of employees: 49
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Radiotherapies
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -92.14% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -92.14% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 60 | 12-02-29 |
Steve O'Loughlin
DFI | Director of Finance/CFO | 39 | 15-10-12 |
Monideepa Roy
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-26 |
Mary Mei Chen
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Avinash Desai
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-18 |
Stephen Dressel
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - | |
Jenny Hsieh
PRN | Corporate Officer/Principal | - | - |
Paul Diamond
LAW | General Counsel | - | 21-06-30 |
Gary Siegel
AUD | Comptroller/Controller/Auditor | 66 | 16-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 13-11-07 | |
C. Nicholson
BRD | Director/Board Member | 69 | 07-12-31 |
Ajit Shetty
BRD | Director/Board Member | 77 | 17-03-27 |
Sandesh Seth
CEO | Chief Executive Officer | 60 | 12-02-29 |
Jeffrey Chell
BRD | Director/Board Member | 70 | 18-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,783,451 | 29,147,811 ( 97.87 %) | 0 | 97.87 % |
Company contact information
Actinium Pharmaceuticals, Inc.
100 Park Avenue 23rd floor
10017, New York
+646 677 3870
http://www.actiniumpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.84% | 239M | |
+18.10% | 123B | |
+14.64% | 107B | |
-4.60% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-12.21% | 16.23B | |
+2.70% | 13.43B | |
+24.25% | 11.32B |
- Stock Market
- Equities
- ATNM Stock
- Company Actinium Pharmaceuticals, Inc.